Gestational Diabetes Market Shaped by Advances in Diagnostic Solutions

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Gestational Diabetes Market Be By 2030 Compared To Its 2026 Market Size?

The gestational diabetes market size has demonstrated strong expansion in recent years. It is anticipated to increase from $9.11 billion in 2025 to $9.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. Historically, this growth can be ascribed to elements such as escalating obesity rates, a rise in pregnancies at higher maternal ages, the establishment of early diabetes screening programs, an increase in prenatal care services, and heightened awareness of pregnancy complications.

The gestational diabetes market is projected to experience substantial expansion in the coming years, anticipated to reach $13.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. The anticipated growth over the forecast period is primarily driven by factors such as the increasing prevalence of gestational diabetes, the widening adoption of digital health monitoring, advancements in prenatal diagnostics, a greater emphasis on preventive maternal care, and supportive healthcare policies. Key trends observed during this period encompass the increasing acceptance of blood glucose monitoring, a rise in the application of insulin therapy during pregnancy, an evolving focus on lifestyle-centric disease management, the proliferation of prenatal screening initiatives, and heightened maternal health awareness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

What Significant Factors Are Influencing The Gestational Diabetes Market Expansion?

The growing number of individuals classified as obese is anticipated to fuel expansion in the gestational diabetes market. This demographic includes persons with a body mass index (BMI) of 30 or above, signifying unhealthy levels of body fat that can lead to serious health concerns. The increase in obesity stems from several factors, such as inactive lifestyles, higher intake of calorie-dense, processed foods, hereditary tendencies, and insufficient availability of nutritious food and opportunities for physical activity. Managing gestational diabetes is vital for obese individuals as their elevated susceptibility to insulin resistance and significant weight gain during gestation can result in adverse outcomes for both the mother and the infant if not properly addressed. For example, data released in May 2025 by the Office for Health Improvement and Disparities, a UK government organization, indicated that between 2023 and 2024, approximately 64.5% of adults aged 18 and over in England were either overweight or obese, an increase from 64.0% recorded from 2022 to 2023. Consequently, the expanding obese population is acting as a primary driver for the gestational diabetes market.

How Is The Gestational Diabetes Market Categorized Across Its Segment Groups?

The gestational diabetes market covered in this report is segmented –

1) By Type: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological Treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

What Trends Are Affecting The Direction Of The Gestational Diabetes Market?

Companies in the gestational diabetes market are concentrating on creating technologically advanced products, such as diagnostic kits for gestational diabetes, to offer quick, accurate, and convenient methods for early detection. A diagnostic kit for gestational diabetes is a medical instrument used to gauge blood glucose levels and identify atypical glucose tolerance in pregnant women, thereby assisting in the prompt discovery and management of the condition. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a diagnostic kit designed for the diagnosis of gestational diabetes, endometriosis, insulin resistance, and liver disease. This kit accurately measures 2-hydroxybutyrate (2-HB) levels found in venous blood, which are naturally produced by the liver during its normal functions. Elevated 2-HB levels are linked to increased reductive stress, which is associated with various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any existing clinical analyzer and provides results in just 8 minutes, presenting a rapid and efficient diagnostic solution.

Which Firms Are Influencing Competition In The Gestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Dexcom Inc, Biocon Limited, Ascensia Diabetes Care Holdings AG, Roche Diabetes Care, Medtronic plc, Insulet Corporation, Tandem Diabetes Care Inc, Ypsomed Holding AG, Beta Bionics Inc, Bigfoot Biomedical Inc, Glooko Inc, Philips Healthcare, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Company Ltd, Pfizer Inc, Novartis AG, Adocia SA, Daiichi Sankyo Company Ltd

Get The Full Gestational Diabetes Market Report:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

Which Region Holds The Highest Market Share In The Gestational Diabetes Market?

North America was the largest region in the gestational diabetes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gestational Diabetes Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

Browse Through More Reports Similar to the Global Gestational Diabetes Market 2026, By The Business Research Company

Diabetes Care Devices Market 2026

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Type 1 Diabetes Market Report 2026

https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report

Insuman Market Report 2026

https://www.thebusinessresearchcompany.com/report/insuman-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795